Gene · 962
CD48: CD48 molecule
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CD48: CD48 molecule. Genes, record 962. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/962
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| P09326 | CD48 antigen | 243 | 1 | Ensembl, GeneID, HGNC |
Source UniProt
Patents97
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| JP 2026004568 A | 2026-01-14 | 40579 | P09326 | Espacenet |
| JP 2025183333 A | 2025-12-16 | 77 | P09326 | Espacenet |
| EP 4650780 A2 | 2025-11-19 | 8356 | P09326 | Espacenet |
| WO 2025235604 A1 | 2025-11-13 | 282 | P09326 | Espacenet |
| WO 2025235605 A1 | 2025-11-13 | 282 | P09326 | Espacenet |
| EP 4641201 A2 | 2025-10-29 | 8536 | P09326 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 2367 | P09326 | Espacenet |
| JP 2025147176 A | 2025-10-06 | 17028 | P09326 | Espacenet |
| EP 4619424 A2 | 2025-09-24 | 32 | P09326 | Espacenet |
| JP 2025529142 A | 2025-09-04 | 821 | P09326 | Espacenet |
1 to 10 of 97
See all 97 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,184
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CD48 papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 27 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 12 | 2025 |
| P30DK043351 | Center for the Study of Inflammatory Bowel Disease at Massachusetts General Hospital | 10 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 9 | 2025 |
| P30CA013330 | Cancer Center Support Grant | 8 | 2025 |
| P01CA066996 | Development of Novel Therapeutic Strategies in Human Leukemias | 7 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 7 | 2025 |
| P30AI050410 | The University of North Carolina Center for AIDS Research | 6 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 6 | 2025 |
| P30CA016087 | Cancer Center Support Grant | 6 | 2025 |
1 to 10 of 2,184Source NIH's project files
See all 2,184 nih grantsPapers3,378
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative Omics Analysis Reveals a CD206+ Macrophage/Dendritic Cell-CD155-TIGIT+ Regulatory T Cell Axis as a Protective Immune Checkpoint Pathway in Atherosclerosis Progression. | Barrier Immun | 2026 | 42819567 | PubTator, text mining | PubMed |
| Radiation-induced SLAMF1 reconfigures the SLAM family receptors landscape in triple-negative breast cancer cells. | J Cancer | 2026 | 42807708 | PubTator, text mining | PubMed |
| Alternative splicing of CD244 restrains natural killer cells at the maternal-fetal interface. | Mucosal Immunol | 2026 | 42805341 | PubTator, text mining | PubMed |
| Dual targeting of CD244 and CD2 by a viral-immunoevasin-guided engineered CD48-Fc mutant for T- and NK-cell modulation. | Front Immunol | 2026 | 42746293 | PubTator, text mining | PubMed |
| Role of spin-orbit and nuclear motion assisted spin-orbit coupling on the structural isomerism dependent intersystem crossing mechanism. | J Chem Phys | 2026 | 42635283 | PubTator, text mining | PubMed |
| Irradiated CD19 chimeric antigen receptor YTS cells retain antitumor activity and offer a scalable alternative to autologous CAR-T therapy. | Haematologica | 2026 | 42610426 | PubTator, text mining | PubMed |
| CD48 and CXCR4 as immune-associated biomarkers in periodontitis: an integrative analysis and validation study. | Front Immunol | 2026 | 42465757 | PubTator, text mining | PubMed |
| CD48 expression in T-lymphoblastic leukemia/lymphoma and mature T-cell neoplasms: role in detecting measurable residual disease and potential confounders, a single-institution retrospective review. | Am J Clin Pathol | 2026 | 42269000 | PubTator, text mining | PubMed |
| Exploring the gut-lung axis in post-liver transplant acute lung injury: A multi-omics approach. | Acta Microbiol Immunol Hung | 2026 | 42258310 | PubTator, text mining | PubMed |
| Extending structural surfaceomics to identify aberrant conformations of tumor surface proteins as potential immunotherapy targets. | bioRxiv | 2026 | 42239335 | PubTator, text mining | PubMed |
1 to 10 of 3,378
See all 3,378 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/962
GET https://conductscience.org/api/genes/v1/962/patents?page=2